Filing Details
- Accession Number:
- 0001019687-12-002559
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-01 08:13:32
- Reporting Period:
- 2012-07-30
- Filing Date:
- 2012-08-01
- Accepted Time:
- 2012-08-01 08:13:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1140098 | Advanced Cell Technology Inc. | ACTC | Pharmaceutical Preparations (2834) | 870656515 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1317093 | Robert Lanza | C/O Advanced Cell Technology 33 Locke Drive Marlborough MA 01752 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Disposition | 2012-07-30 | 611,707 | $0.08 | 27,917,296 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2012-07-30 | 151,500 | $0.08 | 27,765,796 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2012-07-30 | 546,793 | $0.08 | 27,219,003 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2012-07-30 | 190,000 | $0.08 | 27,029,003 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2012-07-31 | 500,000 | $0.08 | 26,529,003 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |